Moolec Science SA Ordinary Shares (MLEC) - Total Liabilities
Based on the latest financial reports, Moolec Science SA Ordinary Shares (MLEC) has total liabilities worth $28.58 Million USD as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Moolec Science SA Ordinary Shares - Total Liabilities Trend (2021–2025)
This chart illustrates how Moolec Science SA Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. See MLEC current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Moolec Science SA Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of Moolec Science SA Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Volato Group Inc.
NYSE MKT:SOAR
|
USA | $13.80 Million |
|
The Dixie Group Inc
NASDAQ:DXYN
|
USA | $166.36 Million |
|
Wellard Ltd
AU:WLD
|
Australia | AU$2.67 Million |
|
Hilton Food Group Plc
LSE:HFG
|
UK | GBX961.20 Million |
|
Ahlada Engineers Limited
NSE:AHLADA
|
India | Rs785.46 Million |
|
Silver Wolf Exploration Ltd
V:SWLF
|
Canada | CA$513.59K |
|
Alpha Compute Corp
NASDAQ:ALP
|
USA | $21.70 Million |
|
Riwi Corp
V:RIWI
|
Canada | CA$2.92 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Moolec Science SA Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Moolec Science SA Ordinary Shares.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 10.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.91 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Moolec Science SA Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Moolec Science SA Ordinary Shares (2021–2025)
The table below shows the annual total liabilities of Moolec Science SA Ordinary Shares from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $287.58 Million | +928.14% |
| 2024-06-30 | $27.97 Million | +100.58% |
| 2023-06-30 | $13.95 Million | +241.18% |
| 2022-06-30 | $4.09 Million | -9.31% |
| 2021-06-30 | $4.51 Million | -- |
About Moolec Science SA Ordinary Shares
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans… Read more